36 Participants Needed

Accelerated Recovery Program for Liver Surgery

HT
Overseen ByHop Tran Cao, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a special recovery plan can help patients leave the hospital sooner after liver surgery. Participants will follow various recovery methods, with one group possibly going home the same day as the surgery. The trial requires participants to complete 14 questionnaires over a month to track their recovery experiences. It is suitable for those with a specific type of liver tumor that can be treated with minimally invasive surgery and who can remain nearby the hospital after surgery. As an unphased trial, it offers a unique opportunity to contribute to innovative recovery strategies and potentially benefit from cutting-edge care.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this accelerated recovery protocol is safe for liver surgery patients?

Research has shown that enhanced recovery programs, like the one under study, are generally safe and well-tolerated. These programs can reduce hospital stays and improve recovery for liver surgery patients by encouraging early movement, minimizing painkiller use, and promoting a quicker return to normal eating.

One study found that following the program's steps significantly shortened hospital stays. Another study noted that patients who adhered to these steps experienced better short-term outcomes, such as fewer post-surgery complications.

Overall, the safety data for these programs is promising. They have been successfully used in similar surgeries, suggesting they are safe for most people.12345

Why are researchers excited about this trial?

Researchers are excited about the Accelerated Recovery Program for liver surgery because it aims to significantly reduce recovery time compared to standard post-operative care. This innovative protocol allows some patients to potentially be discharged on the same day as their minimally invasive surgery, thanks to a focused recovery plan that includes a clear liquid diet, encouragement of independent movement, and minimized opioid use. By integrating telehealth follow-ups and efficient discharge procedures, this approach could enhance patient convenience and reduce hospital stays, which are big wins for both patients and healthcare systems.

What evidence suggests that this trial's treatments could be effective for accelerated recovery after liver surgery?

Research has shown that the Accelerated Recovery Program, also known as Enhanced Recovery After Surgery (ERAS), offers significant benefits for liver surgery patients. In this trial, participants in the Accelerated Recovery Protocol arm will follow a recovery pathway that may allow discharge on the day of surgery. Studies have found that these protocols help patients leave the hospital sooner and recover more quickly. Patients in this program often experience less pain and require fewer painkillers. Additionally, these programs are associated with fewer post-surgery complications. Overall, evidence suggests that an accelerated recovery program can help patients recover faster and more comfortably after minimally invasive liver surgery.12567

Who Is on the Research Team?

HT

Hop Tran Cao, MD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

This trial is for adults over 18 without cirrhosis who have a liver tumor that can be removed with minimally invasive surgery. Participants must not have serious heart or lung conditions, should stay close to the medical center post-surgery, and must understand and sign consent.

Inclusion Criteria

My liver tumor can be removed with a minimally invasive surgery.
Ability to understand and the willingness to sign a written informed consent document
I don't have serious heart or lung conditions that would stop me from having minimally invasive surgery.
See 3 more

Exclusion Criteria

I have been diagnosed with cirrhosis.
Pregnant patients
My tumor cannot be removed with minimally invasive surgery.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo minimally invasive liver resection with an accelerated recovery protocol or standard recovery pathway

1 day
In-person surgery and post-operative assessment

Post-operative Monitoring

Participants are monitored post-surgery with telehealth visits on post-operative days 1 and 2, and an in-person clinic visit within 14 days of discharge

14 days
2 telehealth visits, 1 in-person visit

Follow-up

Participants complete questionnaires over a 30-day period to assess recovery

30 days

What Are the Treatments Tested in This Trial?

Interventions

  • Questionnaires
Trial Overview The study tests whether an accelerated recovery program helps patients leave the hospital sooner after minimally invasive liver surgery. It involves following specific procedures and completing questionnaires.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Comparison/Control ArmExperimental Treatment1 Intervention
Group II: Accelerated Recovery ProtocolExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

Intuitive Surgical Inc

Collaborator

Trials
1
Recruited
40+

Published Research Related to This Trial

Enhanced recovery protocols may lead to a shorter hospital stay and reduced costs for patients undergoing major upper gastrointestinal, liver, and pancreatic surgeries, based on a review of 10 studies involving 1014 participants.
Despite these potential benefits, the overall quality of evidence is low, and the trials showed a high risk of bias, indicating that further research is needed to confirm these findings and assess long-term outcomes.
Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery.Bond-Smith, G., Belgaumkar, AP., Davidson, BR., et al.[2022]
A modified fast-track program for liver resection, involving early mobilization and high-dose methylprednisolone, resulted in a median hospital stay of just 4 days, demonstrating its efficacy in hastening recovery.
The program was safe, with a 6% readmission rate and zero 30-day mortality, indicating that early discharge after major liver surgery is feasible and effective.
Second Generation of a Fast-track Liver Resection Programme.Schultz, NA., Larsen, PN., Klarskov, B., et al.[2018]
In a study of 64 patients undergoing liver resections in a fast-track program, the median hospital length of stay (LOS) was significantly reduced to 6 days compared to 8 days in a historical cohort of 62 patients, indicating improved recovery protocols.
Factors that prolonged LOS in the fast-track group included the presence of complications, the extent of liver resection, and the ability to drink more than 1250 ml of fluid the day after surgery, highlighting the need for targeted support for patients with limited fluid intake post-surgery.
Fast-track program for liver resection--factors prolonging length of stay.Blind, PJ., Andersson, B., Tingstedt, B., et al.[2015]

Citations

Accelerated Recovery After MIS Hepatectomy (ARAMIS ...Our study will investigate the feasibility of an accelerated recovery program to minimize length of stay (LOS) and facilitate outpatient surgery ...
Feasibility, safety and effectiveness of the enhanced recovery ...Our study highlights the significant benefits of implementing an ERAS protocol for major hepatic resections. By closely adhering to the various components of ...
Finetuning and optimizing an enhanced recovery protocol ...Conclusion. The implementation of an optimized CP in liver surgery resulted in a shorter hospital stay and higher adherence rate to the ERAS-protocol.
Accelerated Recovery Program for Liver SurgeryThe Accelerated Recovery Program, also known as Enhanced Recovery After Surgery (ERAS), has been shown to be safe for liver surgery patients.
Enhanced Recovery after Surgery Programs for Liver ...The meta-analysis demonstrated that enhanced recovery after surgery programs could reduce morbidity, hospital stays and cost, blood loss, and time to bowel ...
Safety and efficacy of the enhanced recovery after surgery ...The aim of this research was to evaluate the efficacy and safety of enhanced recovery after surgery (ERAS) protocol in hepatectomy patients with liver cancer.
Efficacy and safety of enhanced recovery after surgery ...The current meta-analysis indicated that ERAS protocols can significantly improve short-term clinical outcomes in liver transplant recipients, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security